Home > Insider Trading > Filing (0001225208-16-037558)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1200375	Codexis Inc	CDXS	Industrial Organic Chemicals (2860)	710872999

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1509160	Vivo Ventures Fund Vii, L.p.	575 High St Palo Alto CA 94301	No	No	Yes	No
1538309	Vivo Ventures Vii Affiliates Fund, L.p.	575 High St Palo Alto CA 94301	No	No	Yes	No
1565020	Vivo Ventures Vii, Llc	575 High Street, Suite 201 Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-08-03	29,360	$4.30	5,425,079	No	4	S	Indirect	By Vivo Ventures Fund VI, L.P.
Common Stock	Disposition	2016-08-04	48,934	$4.17	5,376,145	No	4	S	Indirect	By Vivo Ventures Fund VI, L.P.
Common Stock	Disposition	2016-08-03	640	$4.30	118,240	No	4	S	Indirect	By Vivo Ventures VII Affiliates Fund, L.P.
Common Stock	Disposition	2016-08-04	1,066	$4.17	117,174	No	4	S	Indirect	By Vivo Ventures VII Affiliates Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Vivo Ventures Fund VI, L.P.
No	4	S	Indirect	By Vivo Ventures Fund VI, L.P.
No	4	S	Indirect	By Vivo Ventures VII Affiliates Fund, L.P.
No	4	S	Indirect	By Vivo Ventures VII Affiliates Fund, L.P.

Footnotes

The price shown is a weighted average sales price. The shares were sold at prices ranging from $4.24 to $4.33 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
These shares are owned directly by Vivo Ventures Fund VII, L.P. Vivo Ventures VII, LLC is its general partner, and as such may be deemed to beneficially own these shares.
The price shown is a weighted average sales price. The shares were sold at prices ranging from $4.15 to $4.33 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
These shares are owned directly by Vivo Ventures Affliates Fund VII, L.P. Vivo Ventures VII, LLC is its general partner, and as such may be deemed to beneficially own these shares.